10-Q: Australian Oilseeds Holdings Reports Significant Losses and Going Concern Doubts Amidst Retail Sales Growth
Quarterly Report
Australian Oilseeds Holdings Ltd. reported a substantial shift from profit to significant losses and a worsening net current liability position for the period ended March 31, 2025, raising substantial doubt about its ability to continue as a going concern, despite strong revenue growth in its retail oils segment.
Summary
- Australian Oilseeds Holdings Ltd. (COOT) reported a net loss of AUD$630,633 for the three months ended March 31, 2025, a significant decline from a profit of AUD$41,185 in the prior year period.
- For the nine months ended March 31, 2025, the company incurred a net loss of AUD$1,597,298, compared to a profit of AUD$2,422,104 in the corresponding period of the previous year.
- Sales revenue increased by 49.8% to AUD$9,430,228 for the three months and by 16.1% to AUD$30,163,944 for the nine months ended March 31, 2025, primarily driven by a 69.4% increase in retail oils sales for the three-month period.
- The company secured new supply contracts with major Australian supermarkets, including 15 Costco Australia stores, 1,050 Woolworths Supermarkets, and 850 Coles supermarket stores.
- Cost of sales increased by 55.7% for the three months and 30.8% for the nine months, largely due to higher material costs (canola seed), packaging, and labor.
- Gross profit decreased by 6.3% for the three months and significantly by 47.1% for the nine months ended March 31, 2025.
- Operating profit turned into a loss of AUD$110,301 for the three months and AUD$267,776 for the nine months, compared to profits in the prior periods.
- Finance expenses surged by 190.4% for the three months and 232.7% for the nine months, attributed to new asset finance repayments, convertible note discount amortization, and trade finance interest.
- The company's net current liability position worsened to AUD$9,622,311 as of March 31, 2025, from AUD$6,965,530 at June 30, 2024.
- Net cash flow from operating activities shifted to an outflow of AUD$1,942,969 for the nine months ended March 31, 2025, from an inflow of AUD$1,259,485 in the prior year.
- The company's total equity shifted to a deficit of AUD$1,012,691 as of March 31, 2025, from an equity position of AUD$907,569 at June 30, 2024.
- Post-reporting date, Arena Investors, LP converted USD$150,000 of debentures into 221,957 shares, and a JSKS loan of AUD$4.9 million was approved for conversion into 4,452,479 shares to meet shareholder equity requirements.
- The company continues to remediate material weaknesses in its disclosure controls and procedures identified in the prior fiscal year.
Sentiment
Score: 3
Explanation: While the company achieved significant revenue growth in its retail segment and secured major supermarket contracts, these positives are heavily outweighed by a substantial shift to net losses, worsening liquidity, negative operating cash flow, and an explicit 'substantial doubt about going concern.' The need for immediate capital raises and existing internal control weaknesses indicate severe financial distress.
Positives
- Sales revenue increased significantly by 49.8% for the three months and 16.1% for the nine months ended March 31, 2025, demonstrating strong top-line growth.
- Retail oils segment experienced substantial growth, with revenue increasing by 69.4% for the three months and 58.2% for the nine months, driven by new supply contracts with major Australian supermarkets (Costco, Woolworths, Coles).
- The company successfully secured supply contracts with 15 Costco Australia stores, 1,050 Woolworths Supermarkets, and 850 Coles supermarket stores, indicating strong market penetration and brand development.
- Four new SKUs were developed to target retail consumers, supporting future product diversification and market reach.
- The Cootamundra facility expansion is underway, supported by an AUD$14 million bank facility, indicating investment in increasing production capacity.
- The company was in compliance with all banking covenants associated with borrowings from the Commonwealth Bank of Australia as of March 31, 2025.
- An AUD$8 million unused facility from the Commonwealth Bank of Australia remains available, providing potential liquidity.
- The company has the ability to draw down an additional US$6 million of redeemable debentures from existing PIPE investors or a US$50 million equity line of credit (ELOC) once the registration statement is lodged.
- Post-reporting date, the conversion of Arena debentures and a significant related party loan (JSKS loan of AUD$4.9 million) into equity helps to improve the company's shareholder equity position and address liquidity concerns.
Negatives
- The company shifted from a profit to a significant net loss of AUD$630,633 for the three months and AUD$1,597,298 for the nine months ended March 31, 2025.
- Gross profit declined by 6.3% for the three months and a substantial 47.1% for the nine months, indicating pressure on margins due to rising cost of sales.
- Operating profit turned into a loss for both the three-month (AUD$110,301) and nine-month (AUD$267,776) periods, reflecting increased operational expenses relative to gross profit.
- Finance expenses increased dramatically by 190.4% for the three months and 232.7% for the nine months, driven by new debt and associated costs.
- The company's net current liability position worsened to AUD$9,622,311 as of March 31, 2025, from AUD$6,965,530 at June 30, 2024, indicating deteriorating short-term liquidity.
- Net cash flow from operating activities turned negative, with an outflow of AUD$1,942,969 for the nine months ended March 31, 2025, a significant reversal from an inflow in the prior year.
- The company's total equity shifted to a deficit of AUD$1,012,691 as of March 31, 2025, from a positive equity position at June 30, 2024.
- A substantial portion of the company's sales (87.9% for the three months ended March 31, 2025) are concentrated among its top five customers, posing a significant concentration risk.
- Material weaknesses in disclosure controls and procedures were identified and are still in the process of remediation, indicating internal control deficiencies.
Risks
- Substantial doubt exists about the Company's ability to continue as a going concern unless it can successfully meet stated objectives and/or raise additional funds from financiers and investors.
- The Company's ability to continue as a going concern is dependent on deriving sufficient cash from business operations and drawing down additional long-term debt from its senior debt provider, Commonwealth Bank of Australia, and/or additional funds from PIPE investors or an equity line of credit.
- Failure to obtain necessary funding could require the Company to realize assets and discharge liabilities other than in the normal course of business and at amounts different from those stated in the financial statements.
- A substantial portion of the Company's products are sold to its top five customers (87.9% for the three months ended March 31, 2025), making the Company highly vulnerable to declines in their sales performance, termination of cooperation, or changes in sales and purchase terms.
- The Company is exposed to market risk, including changes to interest rates and foreign currency exchange rates, although it does not consider these to have a material impact.
- Credit risk exists primarily from cash and cash equivalents and accounts receivable, with a significant portion of receivables concentrated among a few customers.
- Material weaknesses in disclosure controls and procedures were identified as of March 31, 2025, and June 30, 2024, which could adversely affect the Company's ability to record, process, summarize, and report financial information reliably.
Future Outlook
The company projects a net profit before tax of AUD$2.4 million from July 2026 to June 2026, subject to market and weather conditions. Its ability to continue as a going concern and meet future financing requirements is dependent on generating sufficient cash from operations, drawing down additional long-term debt from existing bank facilities, and securing additional funds from PIPE investors or an equity line of credit. There is no assurance that current liquidity sources will be sufficient for long-term capital expenditures, working capital, and other cash requirements.
Management Comments
- "The Company believes that transitioning from a fossil fuel economy to a renewable and chemical free economy is the solution to many health problems the world is facing presently."
- "To that end, the Company is committed to working with suppliers and customers to eliminate chemicals from the edible oil production and manufacturing systems to supply quality products such as non-GMO oilseeds and organic and non-organic food-grade oils to customers globally."
- "The Company has determined that the Company’s sources of liquidity will be sufficient to meet the Company’s financing requirements for the one-year period from the issuance of its consolidated financial statements."
Industry Context
Australian Oilseeds Holdings Ltd. operates in the edible oils and oilseeds market, focusing on chemical-free, non-GMO, and sustainable products, aligning with growing consumer demand for healthier and ethically sourced food. The company's strategic expansion into major Australian supermarket channels (Costco, Woolworths, Coles) reflects a common industry trend of seeking broader retail market penetration. The impact of weather conditions on protein meal demand highlights the agricultural sensitivity inherent in the oilseeds processing industry.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Internal Control Weaknesses | Material weaknesses in the design or operation of disclosure controls and procedures, as well as internal control over financial reporting, were identified in the Annual Report on Form 10-K/A for the fiscal year ended June 30, 2024, and are still in the process of remediation as of March 31, 2025. | 2024-06-30 | These weaknesses are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information reliably. |
| Financial Statement Restatement | The consolidated balance sheet as of June 30, 2023, was restated due to previously identified issues. | 2023-06-30 | Indicates past accounting inaccuracies requiring correction. |
Related Party Transactions
- Loans to/from JSKS Enterprises Pty Ltd. (trustee of Gary Seaton Family Trust) with a 6% per annum interest rate, with current and non-current portions outstanding.
- Loans to/from Energreen Nutrition Australia Pty Ltd. (controlled by Gary Seaton) with a 6% per annum interest rate, expected to be repaid within 12 months.
- Interest-free loan owed to CQ Oilseeds Pty Ltd.
- Promissory notes issued to American Physicians, LLC on March 21, 2024, totaling USD$950,000, accruing interest at term SOFR.
- Purchases of seed, oils, sales of meals, other sales, management fees, and leases with Energreen Nutrition Australia Pty Ltd., Soon Soon Oilmills Sdn Bhd. (20% owned by Gary Seaton), and Sunmania Pty Ltd.
Stakeholder Impact
- Shareholders face significant risk due to substantial losses, negative earnings per share, and the explicit 'going concern' doubt, which could lead to further share price depreciation and dilution from potential future capital raises.
- Creditors, particularly those with short-term exposure, face increased risk given the worsening net current liability position and the company's overall financial instability, despite current compliance with banking covenants.
- Customers benefit from expanded product availability through new contracts with major supermarkets, but the company's financial health could impact long-term supply stability.
- Employees may face uncertainty given the company's financial challenges, although increased labor costs in the current period suggest ongoing operations.
Next Steps
- Lodge the registration statement for the US$50 million equity line of credit (ELOC).
- Continue efforts to generate sufficient cash from business operations.
- Potentially draw down additional long-term debt from the AUD$8 million unused facility with Commonwealth Bank of Australia.
- Potentially draw down additional US$6 million redeemable debentures from PIPE investors.
- Remediate material weaknesses in disclosure controls and procedures.
- Work towards achieving the projected AUD$2.4 million net profit before tax from July 2026 to June 2026.
Key Dates
| Date | Description |
|---|---|
| 2022-12-07 | Business combination agreement announced between AOI, PubCo, and EDOC. |
| 2023-08-23 | Securities Purchase Agreement dated between the Company, AOI, EDOC, certain AOI subsidiaries and Arena Investors, LP (the PIPE Investors) for Arena Warrants and Debentures. |
| 2024-02-14 | Company issued a note for an equipment loan to the Commonwealth Bank of Australia for AUD$4,000,000. |
| 2024-02-29 | Company entered into Amendment No.3 to the Securities Purchase Agreement for the purchase and sale of Debentures and Warrants. |
| 2024-03-06 | Extraordinary general meeting of EDOC's shareholders approved the Business Combination and other proposals. |
| 2024-03-21 | Closing Date of the Business Combination, where EDOC merged into Merger Sub and Pubco acquired all outstanding ordinary shares of AOI. Also, Company issued two promissory notes to American Physicians, LLC. |
| 2024-03-22 | Ordinary Shares and PubCo Warrants commenced trading on the Nasdaq Capital Market under symbols COOT and COOTW, respectively. |
| 2024-05-19 | Commencement of quarterly payments for the Secured Bank Loan. |
| 2024-06-01 | Beginning of period for volatility and risk-free rate calculation for warrants. |
| 2024-06-30 | Fiscal year end for which Annual Report on Form 10-K/A was filed, and comparative balance sheet date. |
| 2024-09-21 | First payment due date for the First Promissory Note to American Physicians, LLC. |
| 2024-12-01 | Beginning of period for volatility and risk-free rate calculation for warrants. |
| 2024-12-21 | Second payment due date for the First Promissory Note to American Physicians, LLC. |
| 2025-03-21 | Third payment due date for the First Promissory Note to American Physicians, LLC; also, 12-month anniversary of the Closing of the Business Combination for Escrow Property release. |
| 2025-03-31 | End of the quarterly reporting period for this Form 10-Q. |
| 2025-04-28 | Arena Investors, LP issued conversion notice for USD$150,000 of debentures. |
| 2025-05-20 | Shares transferred to Arena Investors, LP based on conversion notice. |
| 2025-05-22 | Board approved conversion of JSKS loan to equity, and shares were transferred. |
| 2025-05-29 | Date of ordinary shares issued and outstanding count (27,898,538 shares). |
| 2025-05-30 | Date of signing of the Quarterly Report on Form 10-Q. |
| 2025-06-21 | Fourth payment due date for the First Promissory Note and first payment due date for the Second Promissory Note to American Physicians, LLC. |
| 2025-09-21 | Second payment due date for the Second Promissory Note to American Physicians, LLC. |
| 2025-12-21 | Remaining balance due date for the Second Promissory Note to American Physicians, LLC. |
| 2025-12-31 | End date of Cootamundra land lease. |
| 2026-06-30 | End of projected period for AUD$2.4 million net profit before tax. |
| 2035-10-31 | End date of solar power system lease. |
Recommendation
sellKeywords
Oilseeds, Edible Oils, Non-GMO, Sustainable, Cold Pressing, Protein Meals, Retail Oils, Wholesale Oils, SEC Filing, 10-Q, Financial Results, Going Concern, Liquidity, Capital Raise, Australia, Food Industry, Agricultural Products
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.